Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vividion Therapeutics

Request full access

Expanding the therapeutic potential of small molecules

San Diego, United StatesFounded 2014Biotech & Life Sciences

About Vividion Therapeutics

Vividion Therapeutics is a biopharmaceutical company that operates as a wholly owned and independently operated subsidiary of Bayer AG. The company focuses on the development of small-molecule therapeutics for oncology and immunology indications. Its proprietary chemoproteomic platform technology allows for the identification of previously unknown, or "undruggable," protein targets, enabling the discovery of novel drugs.

The company's business model is centered on research and development, with a pipeline of candidates in various stages of preclinical and clinical development. Vividion collaborates with its parent company, Bayer, to advance its programs, benefiting from the larger company's resources and expertise while maintaining its operational independence. The company's revenue is primarily generated through milestone payments and royalties from its collaboration and licensing agreements.

Source: Dealroom company data

At a glance

Outcome tier
Unicorn$1–10B valuation tierColt$25–100M revenue

Vividion Therapeutics in the San Diego ecosystem

Live from Dealroom

The Vividion Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

Series B and later16 investors entered at this stage

Employees mapped 268 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States98.7%
🇩🇪 Germany0.8%
🇦🇪 United Arab Emirates0.4%
3 countries shown
Web traffic by country
7.2K monthly visits
across markets
🇺🇸 United States81.9%
🇮🇳 India15.3%
🇩🇪 Germany4.2%
Top 3 markets shown

Patents

Estimated portfolio value
$1M

17 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vividion Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vividion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.